Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 138

Sort by

Sort Order Select

Journal Articles

Norsworthy KJ, Bird ST, Avagyan A, et al. Second cancers in adults with acute promyelocytic leukemia (APL) treated with or without arsenic trioxide (ATO): a SEER-Medicare analysis [abstract]. Blood. 2019;134(suppl 1). Abstract 3497.

Blood (2020) 135 (23): 2111.

https://doi.org/10.1182/blood.2020006455

Published: 2020

Journal Articles

Hispanic and Black Patients with Adult B-Cell Acute Lymphoblastic Leukemia Have a Significantly Worse Survival in the Modern Era - a SEER 2010-2016 Analysis

Nishi Shah, MBBS, MPH, Mohammad Kazemi, Stephen Zachary Peeke, MD, Lizamarie Bachier-rodriguez, R.Alejandro Sica, MD, Noah Kornblum, MD, Ira Braunschweig, MD, Aditi Shastri, MD, Amit Verma, MBBS, Ioannis Mantzaris, MD MS

Blood (2019) 134 (Supplement_1): 426.

https://doi.org/10.1182/blood-2019-123168

Published: 2019

Journal Articles

Population Level Outcomes of Chronic Lymphocytic Leukemia in the Era of Targeted Agents- Analysis of Surveillance Epidemiology and End Results (SEER) Database

Ravi Kishore Narra, MD MBBS, Ehab L. Atallah, MD, Mehdi Hamadani, MD, Guru Subramanian Guru Guru Murthy, MBBS

Blood (2019) 134 (Supplement_1): 1757.

https://doi.org/10.1182/blood-2019-130211

Published: 2019

Journal Articles

Second Cancers in Adults with Acute Promyelocytic Leukemia (APL) Treated with or without Arsenic Trioxide (ATO): A SEER-Medicare Analysis

Kelly J. Norsworthy, MD, Steven T. Bird, PhD PharmD, MS, Armen Avagyan, MS, Yuchen Li, MS, Sandia Akhtar, BS, Jiemin Liao, MA, Michael Wernecke, BA, Albert B. Deisseroth, MD PhD, Meredith Chuk, MD, Thomas E. MaCurdy, PhD, Richard Swain, PhD, Jeffrey A. Kelman, MD MMSc, Ann T. Farrell, MD, Richard Pazdur, MD, Gideon Blumenthal, MD, David J. Graham, MD MPH

Blood (2019) 134 (Supplement_1): 3497.

https://doi.org/10.1182/blood-2019-130295

Published: 2019

Journal Articles

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Christine G. Kohn, PharmD, Gary H. Lyman, MD MPH, Nicole M. Kuderer, Thomas J. Bunz, PharmD, PhD, Craig I. Coleman, PharmD

Blood (2019) 134 (Supplement_1): 3673.

https://doi.org/10.1182/blood-2019-128581

Published: 2019

Journal Articles

Treatment Patterns and Outcomes in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents: A SEER-Medicare Analysis

Eytan M. Stein, MD, Dominick Latremouille-Viau, George J Joseph, Sherry Shi, Annie Guerin, MSc, Eric Q Wu, Gaetano Bonifacio, Xiting Cao

Blood (2019) 134 (Supplement_1): 3495.

https://doi.org/10.1182/blood-2019-124878

Published: 2019

Journal Articles

Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AML

Ivy Abraham, MD, Garth Rauscher, PhD MPH, Anand Ashwin Patel, MD, Wendy Stock, MD, Maryam Zia, MD, Sushma Bharadwaj, MD, Koosha Paydary, MD, Maria Acevedo-Mendez, John P Galvin, MDMS,MPH, William Pearse, MD, Jessica K. Altman, John G. Quigley, Priya Rajakumar, MD, Melissa L. Larson, MD, Irum Khan, MD

Blood (2019) 134 (Supplement_1): 3413.

https://doi.org/10.1182/blood-2019-124974

Published: 2019

Journal Articles

Center Effects on Outcomes in the Treatment of Acute Myelogenous Leukemia (AML): A Multilevel, Community-Based, Case-Controlled Study

Charles F. Lemaistre, MD, Ju-Hsien Chao, DO, Tonya Cox, BSN, RN, Jose Carlos Cruz, MD, William B. Donnellan, MD, Alireza Eghtedar, MD, Jared Holder, MA, Suman Kambhampati, MD, Shahbaz Malik, Michael B. Maris, MD, Marcello Rotta, MD, Frank Thomas Slovick, MD, Minoo Battiwalla, MD

Blood (2019) 134 (Supplement_1): 4780.

https://doi.org/10.1182/blood-2019-130640

Published: 2019

Journal Articles

Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes

Arushi Khurana, MBBS, Taha Al-Juhaishi, MD, Victor Yazbeck, MD, Danielle Shafer, DO

Blood (2019) 134 (Supplement_1): 4013.

https://doi.org/10.1182/blood-2019-132011

Published: 2019

Journal Articles

Analysis of Outcomes of Younger (≤ 55 Years) Compared with Older (> 55 Years) Patients with Chronic Lymphocytic Leukaemia (CLL) in Seven Studies Conducted By the German CLL Study Group (GCLLSG)

Nisha De Silva, MBBS, MRCP, FRCPath, Sandra Robrecht, PhD, Can Zhang, PhD, Paula Cramer, Anna- Maria Fink, MD, Kirsten Fischer, MD, Valentin Goede, MD, Carmen D. Herling, MD PhD, Manuela Hoechstetter, MD, Clemens-Martin Wendtner, MD, Michael Hallek, MD, Barbara F. Eichhorst, MD

Blood (2019) 134 (Supplement_1): 4293.

https://doi.org/10.1182/blood-2019-126528

Published: 2019

Journal Articles

Demographics and Survival in Primary Effusion Lymphoma: SEER Database Analysis

John Khoury, MD, Christopher Allen Willner, DO, Bolanle Gbadamosi, MD, Susanna Gaikazian, MD, Ishmael Jaiyesimi, DO, MS

Blood (2018) 132 (Supplement 1): 5397.

https://doi.org/10.1182/blood-2018-99-115473

Published: 2018

Journal Articles

Real-World Treatment Patterns and Comparative Effectiveness Among a Population of Elderly Patients with Acute Myeloid Leukemia (AML)

Bruno C. Medeiros, MD, Sacha Satram-Hoang, Faiyaz Momin, Monika Parisi

Blood (2018) 132 (Supplement 1): 835.

https://doi.org/10.1182/blood-2018-99-111267

Published: 2018

Journal Articles

Acute Lymphocytic Leukemia in the Latin American Population

Elisa Quiroz, MD, Rebecca Nelson, Ibrahim Aldoss, MD, Vinod A. Pullarkat, MD, Thomas Slavin, MD, Guido Marcucci, Eduardo Magalhães Rego, MD PhD, Dan Douer, MD

Blood (2018) 132 (Supplement 1): 5282.

https://doi.org/10.1182/blood-2018-99-120079

Published: 2018

Journal Articles

Health Care and out-of-Pocket (OOP) Costs Among Medicare Beneficiaries Diagnosed with Chronic Myeloid Leukemia (CML)

Kelly Kenzik, PhD, Ravi Bhatia, MD, Grant R Williams, Smita Bhatia, MD MPH

Blood (2018) 132 (Supplement 1): 4730.

https://doi.org/10.1182/blood-2018-99-110742

Published: 2018

Journal Articles

Evaluation and Comparison of Characteristics and Outcomes Among Frontline Multiple Myeloma (FLMM) Patients with and without Stem Cell Transplant Treatment

Ajai Chari, MD, Maneesha Mehra, Mary Slavcev, Annette Lam, Ravi Potluri, Jonathan L Kaufman, MD

Blood (2018) 132 (Supplement 1): 4738.

https://doi.org/10.1182/blood-2018-99-113176

Published: 2018

Journal Articles

Survival Outcomes of Patients with Therapy-Related Acute Myeloid Leukemia in the United States

Raffi Tchekmedyian, BS, Tomas Radivoyevitch, PhD, Aaron T. Gerds, MD MS, Aziz Nazha, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Jaroslaw P. Maciejewski, Matt Kalaycio, MD, Navneet S. Majhail, MD MS, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD PhD MPH

Blood (2018) 132 (Supplement 1): 2298.

https://doi.org/10.1182/blood-2018-99-119535

Published: 2018

Journal Articles

Real-World Differences in Characteristics and Survival of Relapsed AML Patients with and without Transplant

Abdalla Aly, Saurabh Ray, Anuj Shah, PhD, Marc Botteman, MS, MA

Blood (2018) 132 (Supplement 1): 2297.

https://doi.org/10.1182/blood-2018-99-118621

Published: 2018

Journal Articles

Second Primary Malignancies in Peripheral T-Cell Lymphoma, Not Otherwise Specified; A SEER Database Analysis

Ranju Kunwor, MD, Mahesh Nepal, MD, Dominic Ho, MD PhD, Krishna Ghimire, MD

Blood (2018) 132 (Supplement 1): 5923.

https://doi.org/10.1182/blood-2018-99-120194

Published: 2018

Journal Articles

Secondary Skin Involvement in Non-Hodgkin's Lymphoma Does Not Impact Outcomes: SEER Database Analysis

Arushi Khurana, MBBS, Taha Al-Juhaishi, MD, Danielle Shafer, DO

Blood (2018) 132 (Supplement 1): 2895.

https://doi.org/10.1182/blood-2018-99-120257

Published: 2018

Journal Articles

Treatment, HSCT Patterns, and Survival of Elderly Diffuse Large B-Cell Lymphoma Patients in the SEER-Medicare Linked Database

Jaime Shaw, MPH, Lauren Johns, PhD, Christopher Harvey, MS, Catherine Richards, PhD, Christopher Kim, PhD

Blood (2018) 132 (Supplement 1): 3584.

https://doi.org/10.1182/blood-2018-99-111051

Published: 2018

NARROW

Norsworthy KJ, Bird ST, Avagyan A, et al. Second cancers in adults with acute promyelocytic leukemia (APL) treated with or without arsenic trioxide (ATO): a SEER-Medicare analysis [abstract]. Blood. 2019;134(suppl 1). Abstract 3497.

Hispanic and Black Patients with Adult B-Cell Acute Lymphoblastic Leukemia Have a Significantly Worse Survival in the Modern Era - a SEER 2010-2016 Analysis

Population Level Outcomes of Chronic Lymphocytic Leukemia in the Era of Targeted Agents- Analysis of Surveillance Epidemiology and End Results (SEER) Database

Second Cancers in Adults with Acute Promyelocytic Leukemia (APL) Treated with or without Arsenic Trioxide (ATO): A SEER-Medicare Analysis

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Treatment Patterns and Outcomes in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents: A SEER-Medicare Analysis

Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AML

Center Effects on Outcomes in the Treatment of Acute Myelogenous Leukemia (AML): A Multilevel, Community-Based, Case-Controlled Study

Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes

Analysis of Outcomes of Younger (≤ 55 Years) Compared with Older (> 55 Years) Patients with Chronic Lymphocytic Leukaemia (CLL) in Seven Studies Conducted By the German CLL Study Group (GCLLSG)

Demographics and Survival in Primary Effusion Lymphoma: SEER Database Analysis

Real-World Treatment Patterns and Comparative Effectiveness Among a Population of Elderly Patients with Acute Myeloid Leukemia (AML)

Acute Lymphocytic Leukemia in the Latin American Population

Health Care and out-of-Pocket (OOP) Costs Among Medicare Beneficiaries Diagnosed with Chronic Myeloid Leukemia (CML)

Evaluation and Comparison of Characteristics and Outcomes Among Frontline Multiple Myeloma (FLMM) Patients with and without Stem Cell Transplant Treatment

Survival Outcomes of Patients with Therapy-Related Acute Myeloid Leukemia in the United States

Real-World Differences in Characteristics and Survival of Relapsed AML Patients with and without Transplant

Second Primary Malignancies in Peripheral T-Cell Lymphoma, Not Otherwise Specified; A SEER Database Analysis

Secondary Skin Involvement in Non-Hodgkin's Lymphoma Does Not Impact Outcomes: SEER Database Analysis

Treatment, HSCT Patterns, and Survival of Elderly Diffuse Large B-Cell Lymphoma Patients in the SEER-Medicare Linked Database

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only